Addition of Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration and On-Site Cytology to EUS-Guided Fine Needle Biopsy Increases Procedure Time but Not Diagnostic Accuracy
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: Although the diagnostic accuracy of endoscopic ultrasound with fine needle aspiration (EUS-FNA) in pancreas adenocarcinomais high, endoscopic ultrasound with fine needle biopsy (EUS-FNB) is often required in other lesions; in these cases, it may bepossible to forgo initial EUS-FNA and rapid on-site cytology evaluation (ROSE). The aim of this study was to compare the diagnostic accuracyof EUS-FNB alone (EUS-FNB group) with a conventional sampling algorithm of EUS-FNA with ROSE followed by EUS-FNB(EUS-FNA/B group) in nonpancreas adenocarcinoma lesions. Methods: Retrospective cohort study of subjects who underwent EUS sampling of nonpancreatic adenocarcinoma lesions between February2011 and May 2013. Results: Over the study period, there were 43 lesions biopsied in 41 unique patients in the EUS-FNB group and 53 patients in the EUSFNA/B group. Overall diagnostic accuracy was similar between the EUS-FNB and EUS-FNA/B groups (83.7% vs. 84.9%; p=1.0). In thesubgroup of subepithelial mass lesions, diagnostic accuracy remained similar in the EUS-FNB and EUS-FNA/B groups (81.0% and 70.6%;p=0.7). EUS-FNB procedures were significantly shorter than those in the EUS-FNA/B group (58.4 minutes vs. 73.5 minutes; p<0.0001). Conclusions: EUS-FNB without on-site cytology provides a high diagnostic accuracy in nonpancreas adenocarcinoma lesions. There appearsto be no additive benefit with initial EUS-FNA but this requires further study in a prospective study.
Abstract
Background/Aims: Although the diagnostic accuracy of endoscopic ultrasound with fine needle aspiration (EUS-FNA) in pancreas adenocarcinomais high, endoscopic ultrasound with fine needle biopsy (EUS-FNB) is often required in other lesions; in these cases, it may bepossible to forgo initial EUS-FNA and rapid on-site cytology evaluation (ROSE). The aim of this study was to compare the diagnostic accuracyof EUS-FNB alone (EUS-FNB group) with a conventional sampling algorithm of EUS-FNA with ROSE followed by EUS-FNB(EUS-FNA/B group) in nonpancreas adenocarcinoma lesions. Methods: Retrospective cohort study of subjects who underwent EUS sampling of nonpancreatic adenocarcinoma lesions between February2011 and May 2013. Results: Over the study period, there were 43 lesions biopsied in 41 unique patients in the EUS-FNB group and 53 patients in the EUSFNA/B group. Overall diagnostic accuracy was similar between the EUS-FNB and EUS-FNA/B groups (83.7% vs. 84.9%; p=1.0). In thesubgroup of subepithelial mass lesions, diagnostic accuracy remained similar in the EUS-FNB and EUS-FNA/B groups (81.0% and 70.6%;p=0.7). EUS-FNB procedures were significantly shorter than those in the EUS-FNA/B group (58.4 minutes vs. 73.5 minutes; p<0.0001). Conclusions: EUS-FNB without on-site cytology provides a high diagnostic accuracy in nonpancreas adenocarcinoma lesions. There appearsto be no additive benefit with initial EUS-FNA but this requires further study in a prospective study.
참고문헌 (14)
- Hewitt MJ, "EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis", Gastrointest Endosc, 75, pp.319~331 (2012)
- Klapman JB, "Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration", Am J Gastroenterol, 98, pp.1289~1294 (2003)
- Iglesias-Garcia J, "Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses", Am J Gastroenterol, 106, pp.1705~1710 (2011)
- Dumonceau JM, "Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline", Endoscopy, 43, pp.897~912 (2011)
- Watson RR, "Yield and performance characteristics of endoscopic ultrasound-guided fine needle aspiration for diagnosing upper GI tract stromal tumors", Dig Dis Sci, 56, pp.1757~1762 (2011)
- Sepe PS, "EUS-guided FNA for the diagnosis of GI stromal cell tumors: sensitivity and cytologic yield", Gastrointest Endosc, 70, pp.254~261 (2009)
- Iglesias-Garcia J, "Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study", Gastrointest Endosc, 73, pp.1189~1196 (2011)
- Kim GH, "Comparison of 22-gauge aspiration needle with 22-gauge biopsy needle in endoscopic ultrasonographyguided subepithelial tumor sampling", Scand J Gastroenterol, 49, pp.347~354 (2014)
- Krishnan K, "Rapid on-site evaluation of endoscopic ultrasound core biopsy specimens has excellent specificity and positive predictive value for gastrointestinal lesions", Dig Dis Sci, 58, pp.2007~2012 (2013)
- Storch I, "Advantage of EUS Trucut biopsy combined with fine-needle aspiration without immediate on-site cytopathologic examination", Gastrointest Endosc, 64, pp.505~511 (2006)
- Storch I, "Endoscopic ultrasound-guided fine-needle aspiration and Trucut biopsy in thoracic lesions:when tissue is the issue", Surg Endosc, 22, pp.86~90 (2008)
- Saftoiu A, "Endoscopic ultrasound (EUS)-guided Trucut biopsy adds significant information to EUS-guided fine-needle aspiration in selected patients: a prospective study", Scand J Gastroenterol, 42, pp.117~125 (2007)
- Larghi A, "EUS-guided fine-needle tissue acquisition by using a 19-gauge needle in a selected patient population: a prospective study", Gastrointest Endosc, 74, pp.504~510 (2011)
- Varadarajulu S, "Assessment of the technical performance of the flexible 19-gauge EUS-FNA needle", Gastrointest Endosc, 76, pp.336~343 (2012)